Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial-Reference-Cited by-同舟云学术

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

Published:2014-08 Issue:8 Volume:14 Page:706-715
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Low Jenny G,Sung Cynthia,Wijaya Limin,Wei Yuan,Rathore Abhay P S,Watanabe Satoru,Tan Boon Hian,Toh Liying,Chua Lian Tee,Hou Yan'an,Chow Angelia,Howe Shiqin,Chan Wing Ki,Tan Kah Hin,Chung Jasmine S,Cherng Benjamin P,Lye David C,Tambayah Paul A,Ng Lee Ching,Connolly John,Hibberd Martin L,Leo Yee Sin,Cheung Yin Bun,Ooi Eng Eong,Vasudevan Subhash G

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference44 articles.

1. The global distribution and burden of dengue;Bhatt;Nature,2013

2. Surveillance of dengue fever virus: a review of epidemiological models and early warning systems;Racloz;PLoS Negl Trop Dis,2012

3. Dengue;Simmons;N Engl J Med,2012

4. Dengue/dengue haemorrhagic fever: history and current status;Gubler;Novartis Found Symp,2006

5. Antibodies determine virulence in dengue;Halstead;Ann N Y Acad Sci,2009

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Response in Dengue Fever and Clinical Implications;Mosquito-Borne Tropical Diseases [Working Title];2024-08-27

2. Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition;Molecules;2024-08-27

3. Immuno-Haematologic Aspects of Dengue Infection: Biologic Insights and Clinical Implications;Viruses;2024-07-06

4. The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions;npj Viruses;2024-06-21

5. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations;International Journal of Biological Macromolecules;2024-06